Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Research & Development (2022 - 2025)

Historic Research & Development for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $2.7 million.

  • Envoy Medical's Research & Development fell 206.75% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 333.55%. This contributed to the annual value of $10.2 million for FY2024, which is 1365.56% up from last year.
  • Latest data reveals that Envoy Medical reported Research & Development of $2.7 million as of Q3 2025, which was down 206.75% from $2.5 million recorded in Q2 2025.
  • Envoy Medical's 5-year Research & Development high stood at $3.1 million for Q4 2023, and its period low was $935000.0 during Q3 2022.
  • Moreover, its 4-year median value for Research & Development was $2.5 million (2024), whereas its average is $2.3 million.
  • As far as peak fluctuations go, Envoy Medical's Research & Development surged by 11171.17% in 2023, and later tumbled by 1911.62% in 2024.
  • Quarter analysis of 4 years shows Envoy Medical's Research & Development stood at $1.4 million in 2022, then skyrocketed by 111.71% to $3.1 million in 2023, then fell by 19.12% to $2.5 million in 2024, then grew by 9.27% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.5 million for Q2 2025, and $2.7 million during Q1 2025.